Tower Bridge Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.22M Sell
37,203
-630
-2% -$60.4K 0.31% 80
2025
Q4
$3.63M Sell
37,833
-1,855
-5% -$180K 0.37% 68
2025
Q3
$3.78M Sell
39,688
-1,300
-3% -$120K 0.38% 65
2025
Q2
$3.57M Sell
40,988
-416
-1% -$35.3K 0.38% 69
2025
Q1
$3.72M Sell
41,404
-1,154
-3% -$103K 0.42% 69
2024
Q4
$3.4M Sell
42,558
-1,338
-3% -$116K 0.36% 70
2024
Q3
$3.95M Sell
43,896
-5,497
-11% -$462K 0.41% 68
2024
Q2
$3.89M Sell
49,393
-2,110
-4% -$173K 0.43% 65
2024
Q1
$4.49M Sell
51,503
-4,258
-8% -$363K 0.46% 63
2023
Q4
$4.59M Sell
55,761
-4,315
-7% -$329K 0.4% 70
2023
Q3
$4.71M Sell
60,076
-53
-0.1% -$4.44K 0.44% 67
2023
Q2
$5.3M Sell
60,129
-10,253
-15% -$883K 0.49% 62
2023
Q1
$5.67M Sell
70,382
-18,980
-21% -$1.55M 0.46% 66
2022
Q4
$6.95M Sell
89,362
-15,440
-15% -$1.25M 0.58% 53
2022
Q3
$8.46M Sell
104,802
-18,834
-15% -$1.69M 0.75% 39
2022
Q2
$11.1M Sell
123,636
-3,768
-3% -$382K 0.91% 31
2022
Q1
$14.1M Buy
127,404
+615
+0.5% +$65K 0.94% 28
2021
Q4
$13.1M Buy
126,789
+9,590
+8% +$1.11M 0.81% 37
2021
Q3
$14.7M Buy
117,199
+25
+0% +$3.24K 0.98% 30
2021
Q2
$14.5M Sell
117,174
-689
-0.6% -$86.5K 0.97% 28
2021
Q1
$13.9M Sell
117,863
-174
-0.1% -$20.4K 1.05% 28
2020
Q4
$13.8M Buy
118,037
+3,477
+3% +$383K 1.13% 26
2020
Q3
$11.9M Buy
114,560
+10,840
+10% +$1.09M 1.22% 29
2020
Q2
$9.51M Buy
103,720
+2,262
+2% +$217K 1.07% 34
2020
Q1
$9.15M Buy
101,458
+3,285
+3% +$349K 1.2% 26
2019
Q4
$11.1M Buy
98,173
+507
+0.5% +$55.6K 1.18% 30
2019
Q3
$10.5M Sell
97,666
-1,695
-2% -$177K 1.14% 29
2019
Q2
$9.68M Buy
99,361
+4
+0% +$365 1.08% 29
2019
Q1
$9.05M Sell
99,357
-2,793
-3% -$250K 1.05% 34
2018
Q4
$9.29M Buy
102,150
+754
+0.7% +$70.5K 1.2% 30
2018
Q3
$9.97M Sell
101,396
-684
-0.7% -$63.2K 1.04% 33
2018
Q2
$8.74M Sell
102,080
-10,291
-9% -$860K 0.97% 36
2018
Q1
$9.01M Sell
112,371
-25,232
-18% -$2.08M 1% 37
2017
Q4
$11.1M Buy
137,603
+2,905
+2% +$233K 1.19% 33
2017
Q3
$10.5M Buy
134,698
+11,805
+10% +$980K 1.19% 34
2017
Q2
$10.9M Buy
122,893
+773
+0.6% +$65.2K 1.25% 27
2017
Q1
$9.84M Buy
122,120
+2,589
+2% +$202K 1.15% 33
2016
Q4
$8.51M Buy
119,531
+106,873
+844% +$8.4M 1.03% 36
2016
Q3
$1.09M Buy
12,658
+200
+2% +$17.4K 0.13% 111
2016
Q2
$1.08M Hold
12,458
0.13% 111
2016
Q1
$934K Sell
12,458
-150
-1% -$11.3K 0.12% 116
2015
Q4
$970K Buy
12,608
+2,623
+26% +$197K 0.13% 111
2015
Q3
$668K Sell
9,985
-1,050
-10% -$77.3K 0.09% 124
2015
Q2
$818K Sell
11,035
-165
-1% -$12.6K 0.1% 117
2015
Q1
$873K Sell
11,200
-679
-6% -$51.5K 0.11% 115
2014
Q4
$858K Hold
11,879
0.11% 115
2014
Q3
$736K Hold
11,879
0.09% 121
2014
Q2
$757K Sell
11,879
-250
-2% -$15.2K 0.09% 119
2014
Q1
$746K Sell
12,129
-804
-6% -$46.8K 0.1% 116
2013
Q4
$742K Sell
12,933
-1,798
-12% -$102K 0.1% 116
2013
Q3
$784K Buy
14,731
+470
+3% +$25.3K 0.11% 112
2013
Q2
$734K Buy
+14,261
New +$705K 0.11% 118

Other funds holding MDT

Tower Bridge Advisors's MDT Position: Q1 2026 in Review

Tower Bridge Advisors reduced its Medtronic (MDT) stake by 1.7% in Q1 2026, selling an estimated $60.4K and leaving 37,203 shares worth $3.22M. The position accounts for 0.31% of the portfolio, ranked #80.

Tower Bridge Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.7M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Tower Bridge Advisors held 37,203 shares of Medtronic worth $3.22M as of Q1 2026.
  • Tower Bridge Advisors sold 630 Medtronic shares in Q1 2026, an estimated $60.4K.
  • Medtronic made up 0.31% of Tower Bridge Advisors's portfolio in Q1 2026, its #80 holding.
  • Tower Bridge Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Tower Bridge Advisors's Medtronic position peaked at $14.7M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.